GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWY) » Definitions » EPS (Basic)

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) EPS (Basic) : $3.34 (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Carl Zeiss Meditec AG EPS (Basic)?

Carl Zeiss Meditec AG's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was $0.46. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.34.

Carl Zeiss Meditec AG's EPS (Diluted) for the three months ended in Dec. 2023 was $0.46. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.34.

Carl Zeiss Meditec AG's EPS without NRI for the three months ended in Dec. 2023 was $0.46. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 3.34.

During the past 12 months, Carl Zeiss Meditec AG's average EPS without NRIGrowth Rate was -9.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 33.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Carl Zeiss Meditec AG's highest 3-Year average EPS without NRI Growth Rate was 33.40% per year. The lowest was -8.90% per year. And the median was 9.95% per year.

Carl Zeiss Meditec AG EPS (Basic) Historical Data

The historical data trend for Carl Zeiss Meditec AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG EPS (Basic) Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 1.61 3.11 3.26 3.47

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.74 1.12 1.03 0.46

Carl Zeiss Meditec AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Carl Zeiss Meditec AG's Basic EPS for the fiscal year that ended in Sep. 2023 is calculated as

Basic EPS (A: Sep. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(309.921-0)/89.441
=3.47

Carl Zeiss Meditec AG's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(40.785-0)/89.048
=0.46

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG  (OTCPK:CZMWY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Carl Zeiss Meditec AG EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWY) » Definitions » EPS (Basic)
Comparable Companies
XTER:1SXP XTER:FIE XTER:GXI FRA:PHH2 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN XPAR:DIM BAX HOLX COO TSE:7733 TSE:6869
Traded in Other Exchanges
CZMWF:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.